EUVIMED · CrossrefZeitschrift
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
ISSN 1466-0822 · Informa UK Limited
Neueste Artikel
Stem Cell Therapy for ALS: Hope and RealityA discussion paper from the Executive of the European ALS Consortium
El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
Treatable lower motor neuron disease due to vitamin D deficiency and secondary hyperparathyroidism
A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis
Gastrointestinal dysfunction in amyotrophic lateral sclerosis
Palliative care in ALS: searching for the evidence base
Improving the quality of life for people with ALS: The challenge ahead
Motor unit number estimation (MUNE): how may it contribute to the diagnosis of ALS?
Editorial
Animal models of amyotrophic lateral sclerosis
An overview of H-reflex studies in amyotrophic lateral sclerosis
Cyclin-dependent kinase-5 (CDK5) and amyotrophic lateral sclerosis
Preface
Problems in shortening the time to confirmation of ALS diagnosis: lessons from the 1st Consensus Conference, Chicago, May 1998
Cognitive function in amyotrophic lateral sclerosis
The MND Care Facility, Preston, UK
The ALS Center of Montpellier, France
Book Review
Forthcoming meetings
Editorial and Guest Editorial
Mechanism and treatment of motoneuron degeneration in ALS: What have SOD1 mutants told us?
Amyotrophic lateral sclerosis: toxins and environment
Frameshift, nonsense and non amino acid altering mutations in SOD1 in familial ALS: report of a Japanese pedigree and literature review
Expression of nitric oxide synthase isoforms in spinal cord in amyotrophic lateral sclerosis
Agreement among three quality of life measures in patients with ALS
Brown-Vialetto-Van Laere syndrome: Case report and literature review
Book Review
Forthcoming meetings
Editorial and Guest Editorials
Superoxide dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral sclerosis
EUVIMED